Medicine & AI to Improve Outcomes by Discovering Undiagnosed Patients- NHS Clinicians Presenting at HIMSS

Predicting Length-of-Stay & Risk of Mortality for ICU Patients

Pangaea Data Awarded Top Tier Co-Sell Partnership Status by Microsoft

Pangaea Named ‘Digital Solution of the Year’ by UK Government’s Department for International Trade

WHITEPAPER: How can Pharmaceutical & Healthcare Providers Collaborate in a Financially Sustainable & Scalable Manner to Improve Patient Outcomes?

Go back

Medicine & AI to Improve Outcomes by Discovering Untreated Patients

3:10 - 4:00PM CEST, June 17th 2024, DBT Partner Programming- AI in the NHS, Amsterdam, NL

Session & Track: Partner Programming – DBT – AI in the NHS – changing the game

Venue: RAI Amsterdam Convention Centre, Amsterdam, NL

Currently, up to 90% of patients across 7,000 conditions are untreated (undiagnosed, misdiagnosed, miscoded, uncontrolled, at-risk). For example, cachexia (muscle wasting disease) is estimated to impact over 90% of cancer patients and result in 20% of casualties, however, over 50% of these patients are currently untreated. Through the application of AI based on clinical guidelines, NHS oncosurgeons demonstrated to find 6 times more untreated cachectic cancer patients compared to metadata and pre-emptive NLP approaches. The discovery of these untreated patients is leading to improved outcomes, halving treatment costs, improve resource optimisation and ensuring that patients are on guideline concordant therapies or trials.

Meet Us at the DBT Booth (Stand E130) 18th – 20th June

Please let us know if you are available to meet by registering through the form below or emailing us at info@pangaeadata.ai

Register to Meet Us

Presenters & Attendees

Dr. Vibhor Gupta
Director & Founder
Pangaea Data